It counteracts inflammation and oxidative stress in inflammatory skin diseases, obesity, and associated metabolic disorders, in part by inhibiting the kallikrein proteases KLK7 and KLK14. Here, KLK14 is linked to obesity due to melanocortin 4 receptor deficiency.